We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




3D Bioprinter Produces Functional Human Skin

By HospiMedica International staff writers
Posted on 09 Feb 2017
A novel three-dimensional (3D) printing technology uses human components to produce active skin that makes its own collagen.

Researchers at Hospital General Universitario Gregorio Marañón, Universidad Carlos III de Madrid, and other institutions 3D printed a human bilayered (epidermis and ermis) skin using bioinks containing human plasma, primary human fibroblasts, and keratinocytes obtained from skin biopsies. More...
The researchers were able to generate 100 cm2--a standard P100 tissue culture plate--of printed skin in less than 35 min, including the 30 minutes required for fibrin gelation.

When using histological and immunohistochemical methods to analyze the structure and function of the printed skin in immunodeficient mice, they found that both in the 3D and in vitro cultures it was similar to human skin and, furthermore was indistinguishable from hand-made dermo-epidermal equivalents, which usually take three weeks to fabricate. The researchers claim that the human skin produced is adequate for transplant into patients, or for testing drugs and cosmetics. The study describing the technique was published on December 5, 2016, in Biofabrication.

“Knowing how to mix the biological components, in what conditions to work with them so that the cells don't deteriorate, and how to correctly deposit the product is critical to the system,” said study co-author Juan Francisco del Cañizo, MD, of Gregorio Marañón Hospital. “It prints the epidermis, including the stratum corneum, the protective outermost layer comprising keratinized cells. Then, it prints the deeper, thicker dermis, complete with fibroblasts that make collagen.”

“This method of bioprinting allows skin to be generated in a standardized, automated way, and the process is less expensive than manual production,” said Alfredo Brisac, CEO of BioDan Group, a private Spanish bioengineering firm that is commercializing the technology. “The 3D bioprinter has been submitted for approval by various European regulators. The approval is needed to ensure that the printed skin is suitable for transplanting into patients with burns and other skin conditions.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Complete Hip System
Taperloc Complete Hip System
New
Anesthesia Cart
UTGSU-333369-DKB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.